Lichter Jay's Form 4 filing
Janux Therapeutics, Inc.JANX · filed Oct 24, 2024
- Accession no.
- 0001415889-24-025601
- Filed
- Oct 24, 2024
- Trade date
- Sep 13, 2024
- Filing delay
- 41 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $178.1K. It was filed 41 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lichter JayCIK 0001376355 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +1,868 | $17.00 | +$31,756 | 8,868 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +778 | $10.73 | +$8,347.94 | 9,646 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +778 | $13.22 | +$10,285.16 | 10,424 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseAcquired | +391 | $39.80 | +$15,561.8 | 10,815 | Direct | |
| Sep 13, 2024 | Common Stock | SSaleDisposed | −3,815 | $46.68 | −$178,084.2 | 7,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −1,868 | $0.00 | $0 | 27,138 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −778 | $0.00 | $0 | 11,308 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −778 | $0.00 | $0 | 11,308 | Direct | |
| Sep 13, 2024 | Common Stock | MOption exerciseDisposed | −391 | $0.00 | $0 | 7,682 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The number of securities reported in Column 5 of Table I and Column 9 of Table II represent the number of securities beneficially owned immediately following the transactions reported herein and do not reflect transactions that occurred on dates subsequent to the transactions reported herein. Form 4s filed by the reporting person on September 30, 2024 and October 18, 2024 are deemed amended hereby to give effect to the transactions effected on September 13, 2024 reported herein.